Adamas Announces Publication of the Two-Year Phase 3 Open-Label EASE LID 2 Trial of GOCOVRI® for Dyskinesia in Patients with Parkinson’s Disease. Sometimes the dyskinesia…
WebmasterFebruary 20, 2020
© PMD Alliance 2021 All Rights Reserved.